DEUTSCHE BANK AG\ - PREVAIL THERAPEUTICS INC ownership

PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 47 filers reported holding PREVAIL THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of PREVAIL THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$248,000
+210.0%
10,768
+36.6%
0.00%
Q3 2020$80,000
-25.2%
7,882
+9.6%
0.00%
Q2 2020$107,000
+75.4%
7,194
+42.7%
0.00%
Q1 2020$61,000
+52.5%
5,043
+95.8%
0.00%
Q4 2019$40,000
+60.0%
2,575
+25.1%
0.00%
Q3 2019$25,0002,0590.00%
Other shareholders
PREVAIL THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Orbimed Advisors 13,822,463$318,884,0002.79%
HARVEST MANAGEMENT LLC 70,000$1,615,0001.32%
HARVEST MANAGEMENT LLC 70,000$1,615,0001.32%
EQUITEC PROPRIETARY MARKETS, LLC 215,300$4,967,0001.30%
BARDIN HILL MANAGEMENT PARTNERS LP 206,867$4,773,0001.00%
Boxer Capital, LLC 1,123,105$25,910,0000.83%
TIG Advisors, LLC 709,282$16,363,0000.82%
Newtyn Management, LLC 153,617$3,544,0000.82%
ALPINE ASSOCIATES MANAGEMENT INC. 857,705$19,787,0000.81%
GABELLI & Co INVESTMENT ADVISERS, INC. 205,800$4,748,0000.74%
View complete list of PREVAIL THERAPEUTICS INC shareholders